🔎 Trials Near Me

Início › Carcinoma de Células Escamosas de Cabeça e Pescoço › Geórgia

Ensaios clínicos de Carcinoma de Células Escamosas de Cabeça e Pescoço em Geórgia

26 estudos para Carcinoma de Células Escamosas de Cabeça e Pescoço estão buscando participantes em locais em Geórgia.

Cidades em Geórgia

Texto oficial do estudo (Inglês)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06465069

A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • City of Hope - Atlanta /ID# 285268, Newnan
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07744126

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  • Emory University, Atlanta
RecrutandoFase 1
Idades de 18 a 74 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07219212

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • Emory University, Atlanta
  • Central Georgia Cancer Care, Macon
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07276399

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • Emory University Hospital Midtown, Atlanta
RecrutandoFase 3
Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04892173

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • Emory University Hospital Midtown, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06980038

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
RecrutandoFase 2
Idades de 18 a 79 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04671667

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT02734537

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • Morehouse, Atlanta
  • Piedmont Healthcare, Atlanta
  • Winship Cancer Institute, Emory University, Atlanta
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • Emory University School of Medicine, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06769698

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04333537

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Emory University, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT03526835

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Winship Cancer Institute - Emory University, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • University Cancer & Blood Center, Athens
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT06150664

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

  • Emory Midtown University Hospital/Winship Cancer Institute, Atlanta
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06662058

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Winship Cancer Institute, Emory University, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 26 de mai. de 2026 · NCT06256588

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA10-0, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06953089

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

  • Emory University Hospital, Atlanta
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT07203911

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Emory University, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06064877

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

  • Research Site 111, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de abr. de 2026 · NCT05785741

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 4 de mar. de 2026 · NCT06868433

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de fev. de 2026 · NCT06636734

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 114, Atlanta
  • Research Site 139, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de nov. de 2025 · NCT05914116

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

  • Emory University Hospital Midtown, Atlanta
RecrutandoFase 1 inicial
Idades 18 e acima · Todos os sexos · Atualizado em 22 de out. de 2025 · NCT06914999

A Beta-only IL-2 ImmunoTherapY Study

  • Emory - Winship Cancer Institute, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2025 · NCT05086692

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.